Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Idexx Laboratories ( (IDXX) ) is now available.
IDEXX Laboratories has approved a Nonqualified Deferred Compensation Plan allowing select management and high-earning employees to defer parts of their compensation. The Plan provides flexibility in deferral options and includes provisions for discretionary company contributions, promising potential benefits for both the company and its participants.
More about Idexx Laboratories
IDEXX Laboratories, Inc. operates in the healthcare industry, specializing in veterinary diagnostics and information technology solutions. The company focuses on providing innovative products and services for the animal health, water testing, and dairy markets.
YTD Price Performance: -21.25%
Average Trading Volume: 614,497
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $35.79B
For a thorough assessment of IDXX stock, go to TipRanks’ Stock Analysis page.
